Subscribe to our mailing list

Pfizer revenue jumps 14% in 1st quarter

Pfizer posted barely larger gross sales and a 14 % leap in revenue within the first quarter, due to decrease restructuring prices and a much-lower tax fee, however its income nonetheless missed Wall Avenue expectations.

The maker of ache medication Lyrica and the blockbuster Prevnar 13 vaccine in opposition to pneumococcal infections stated Tuesday that web revenue was $three.56 billion (59 cents per share). That was up from $three.12 billion (51 cents) a yr earlier, when there have been extra shares being publicly traded.

The New York firm’s earnings, adjusted for nonrecurring prices, got here to 77 cents per share. That was three cents higher than business analysts had anticipated, in line with Zacks Funding Analysis.

Powered by WPeMatico

Author: Techno Info

VN:F [1.9.22_1171]
Rating: 0.0/10 (0 votes cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)

Author Spotlight